% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

  • fdaplayx fdaplayx Nov 14, 2013 7:33 AM Flag

    AEZS (MC $43 M ) Cash $25 M / 1 Product awaiting FDA approval / 9 Drugs in Phase 2-3

    Check it out guys you have the MEGA opportunity to buy this significantly underpriced stock at the bottom if you want to make money !

    AEZS has already a Drug on the Market which is partnered with pharma giant Merck (MRK) , this Product brings around $70 M in annual revenue to AEZS thats almost two times higher than current Market Cap .

    AEZS has another Drug awaiting FDA approval and muliple Cancer Drugs in Late Stage some of them have potential Blockbusters .

    I think AEZS has the potential for a runup to minimum to $4-5 before FDA decision in Mid 2014 . GL

    AEterna Zentaris (AEZS)

    Market Cap: $43 M
    Cash: $25 M
    Price: $1.35

    Shares Out: 32 M

    Annual Revenue :$ 70 M


    Macimorelin Acetate (AEZS-130)

    Diagnostic in adult growth hormonedeficiency (endocrinology) Awaiting FDA approval

    Product ..Zoptarelin Doxorubicin (AEZS-108)

    Endometrial cancer in Phase 3

    Tripl-negative breast cancer In Phase 2

    Castration-and taxane-resistant prostate cancer in Phase 2

    Refractory bladder cancer in Phase 2

    Ovarian cancer (completed) in Phase 2

    Product ..Ozarelix :

    Prostate cancer in Phase 2

    Product ..Macimorelin Acetate (AEZS-130)

    Therapeutic in cancer cachexia in Phase 2

    Product ..Perifosine

    Multiple cancers in Phase 2


3.42+0.10(+3.01%)Oct 20 4:00 PMEDT